Dr. Sarvaideo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9200 W Wisconsin Ave
# Division
Milwaukee, WI 53226Phone+1 414-955-6723Fax+1 414-955-6210
Summary
- Dr. Jenna Sarvaideo is an endocrinologist in Wauwatosa, WI and is affiliated with multiple hospitals in the area, including Froedtert and the Medical College of Wisconsin Froedtert Hospital and Froedtert and the Medical College of Wisconsin Froedtert Hospital. She received her medical degree from NYIT College Of Osteopathic Medicine and has been in practice 5 years. She specializes in diabetes, gonad disorders & reproductive, and osteoporosis & bone metabolism medicine.
Education & Training
- Medical College of Wisconsin Affiliated HospitalsFellowship, Endocrinology, Diabetes, and Metabolism, 2015 - 2017
- University of ChicagoResidency, Internal Medicine, 2012 - 2015
- NYIT College Of Osteopathic MedicineClass of 2012
Certifications & Licensure
- WI State License 2015 - 2025
- IL State License 2012 - 2015
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Coagulation and Fibrinolysis of Estradiol in Transwomen Start of enrollment: 2021 Dec 07
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 1 citationsTwo Transgender Men Receiving Subdermal Testosterone Pellets for Gender Affirmation.Sune L Wolf Pulsiano, Jenna L Sarvaideo
AACE Clinical Case Reports. 2023-09-30 - 9 citationsEstrogen and the Vascular Endothelium: The Unanswered Questions.Gopika SenthilKumar, Boran Katunaric, Henry Bordas-Murphy, Jenna Sarvaideo, Julie K Freed
Endocrinology. 2023-04-17 - 4 citationsThe Utility of Monitoring Potassium in Transgender, Gender Diverse, and Nonbinary Individuals on Spironolactone.Hailey Hayes, Rachel Russell, Amber Haugen, Sneha Nagavally, Jenna Sarvaideo
Journal of the Endocrine Society. 2022-10-11
Press Mentions
- New Protocol Could Cut Fasting Period to Detect InsulinomasMay 10th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: